GRDN · Guardian Pharmacy Services, Inc. · Documents
$39.56
+0.37 (+0.94%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.48B
Shares
63.34M
Volume · Oct 27
357.19K
Avg daily vol (3M)
492.22K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| 8-K | — | 2026-09-10 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-06 | — | |
| 8-K | — | 2026-06-22 | — | |
| 8-K | — | 2026-05-28 | 2026-05-21 | |
| 8-K | — | 2026-05-07 | 2026-05-05 | |
| 8-K | — | 2026-05-06 | — | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| S-3ASR | — | 2026-05-06 | — | |
| DEFA14A | — | 2026-03-26 | — | |
| DEF 14A | — | 2026-03-26 | 2026-05-05 | |
| 8-K | — | 2026-03-23 | 2026-03-18 | |
| 10-K | — | 2026-03-11 | 2025-12-31 | |
| 8-K | — | 2026-03-11 | — | |
| 8-K | — | 2026-01-13 | — | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | — | |
| S-3 | — | 2025-10-14 | — | |
| 8-K | — | 2025-10-14 | — | |
| 8-K | — | 2025-09-18 | — | |
| 8-K | — | 2025-08-11 | — | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-06-18 | — | |
| S-1 | — | 2025-05-20 | — | |
| 8-K | — | 2025-05-20 | — | |
| 8-K | — | 2025-05-12 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | 2025-05-09 | |
| DEFA14A | — | 2025-03-28 | — | |
| DEF 14A | — | 2025-03-28 | 2025-05-09 | |
| 8-K | — | 2025-03-28 | 2025-03-24 | |
| 8-K | — | 2025-03-26 | — | |
| 10-K | — | 2025-03-26 | 2024-12-31 | |
| 8-K | — | 2025-03-03 | — | |
| 8-K | — | 2025-02-11 | 2025-02-05 | |
| 8-K | — | 2024-12-20 | — | |
| 8-K | — | 2024-11-12 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-09-30 | 2024-09-25 | |
| S-1/A | — | 2024-09-16 | — | |
| S-1/A | — | 2024-08-22 | — | |
| S-1 | — | 2023-10-03 | — |
Showing 1–43 of 43 filings
Key facts
CIK
1802255
CUSIP
40145W101
13F (30d)
19 filings
19 filers
Visit website
Investor relations